Marketing Tools

CRWENewswire.com is pleased to announce a stock highlight on Aquentium, Inc. (OTCBB:AQNM) Sign up to receive FREE stock-pr alerts from CRWENewswire.com http://www.crwenewswire.com/?tag=stock-pr

Aquentium, Inc. (OTCBB:AQNM) announced today July 31 , 2009 that the company’s air purification system is an excellent application for any hotel, hospital, school or office building that is seeking to eliminate viruses and bacteria. The Aquentium air purification will also eliminate odors.

Easy to install and low operating costs make the Aquentium air purification systems an ideal solution for those businesses seeking an immediate solution.

Call today for a customized quote (951) 657-8832.

About Aquentium

Aquentium is a diversified company with an emphasis on green technologies. The company currently has interests in non-chemical sanitation equipment, waste-to-energy, water treatment, food safety, mining, alternative energy, building materials, affordable housing, re-deployable housing, and recycling.

http://www.aquentium.com
email: ir@aquentium.com

Note: Certain statements in this news release may contain “forward looking” information within the meaning of rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Act of 1934 and are subject to the safe harbor created by those rules. There can be no assurance that such forward-looking statements will be accurate and actual results and future events could differ materially from those anticipated in such statements.

Mark Taggatz
Aquentium
PO Box 580943
North Palm Springs, CA 92258
USA

Phone: 760-329-4139

About CRWENewswire.com

CRWENewswire.com is an independent electronic informative online financial news publication company dedicated in providing company associates, business and financial professionals with economic and investment information, as well as stock highlights. CRWENewswire.com is a division of Crown Equity Holdings, Inc.

CRWENewswire.com is not a registered investment advisor or broker-dealer. CRWENewswire.com and Crown Equity Holdings, Inc., (CRWE) affiliates, officers, directors, contractors and employees, including may buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own Due Diligence before investing in any of the stocks mentioned above.
We encourage investors to join and receive CRWENewswire.com FREE e-mail news and stock watch alerts at http://www.crwenewswire.com/?tag=stock-pr and view our full disclaimer.

Las Vegas CRWENewsire - SpongeTech® Delivery Systems, Inc. “The Smarter Sponge™”, (OTCBB: SPNG) is pleased to announced that the Company has booked a record month in new orders at approximately $23.5 million, surpassing June’s orders of $18 million.
SpongeTech® Delivery Systems, Inc. Partners with the Cincinnati Bengals Under this agreement, SpongeTech® will become an official sponsor of the team as well as receive exclusive branding on the team’s practice jersey. SpongeTech® continues to grow its sports sponsorship portfolio in 2009, previously leveraging Major League Baseball teams and the World Football Challenge.

About SpongeTech® Delivery Systems, Inc.
SpongeTech® Delivery Systems is a company which designs, produces, and markets unique lines of reusable cleaning products for Car Care, Child Care, Home Care and Pet Care usages. These sponge-like products utilize SpongeTech®’s proprietary, patent (and patent-pending) technologies and other technologies involving hydrophilic (liquid absorbing) foam, polyurethane matrices or other ingredients. The Company’s sponge-like products are pre-loaded with specially formulated ingredients such as soap, conditioner and/or wax that are released when the sponge is soaked and applied to a surface with minimal pressure. SpongeTech® is currently exploring additional applications for its technology in the health, beauty, and medical markets. SpongeTech® Delivery Systems, Inc. intends to globally brand its products as The Smarter Sponge™

CRWENewswire.com is pleased to announce a stock highlight on Sign up to receive FREE stock-pr alerts from CRWENewswire.com http://www.crwenewswire.com/?tag=stock-pr

About CRWENewswire.com

CRWENewswire.com is an independent electronic informative online financial news publication company dedicated in providing company associates, business and financial professionals with economic and investment information, as well as stock highlights. CRWENewswire.com is a division of Crown Equity Holdings, Inc.
CRWENewswire.com is not a registered investment advisor or broker-dealer. CRWENewswire.com and Crown Equity Holdings, Inc., (CRWE) affiliates, officers, directors, contractors and employees, including may buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own Due Diligence before investing in any of the stocks mentioned above.
We encourage investors to join and receive CRWENewswire.com FREE e-mail news and stock watch alerts at http://www.crwenewswire.com/?tag=stock-pr and view our full disclaimer.

Las Vegas CRWENewswire - Power3 Medical Products, Inc. (OTCBB:PWRM), (www.power3medical.com), announced today that the Company has filed a patent for “Diagnosis of Early Stage Parkinson’s Disease: Abnormal: Blood Serum Concentrations of a Select Group of Protein Biomarkers.”
Power3 Medical Products, Inc. filed a provisional patent on the diagnosis of early stage Parkinson’s disease: abnormal blood serum concentrations of a select group of protein biomarkers. This not only announces to the industry the progress of the Nuro-Pro-PD test for Parkinson’s, in validation, utility, but that the importance of the Power3 protein biomarkers are statistically valid for use as a diagnostic test. This work was done in conjunction with Transgenomic, Inc. license/collaboration agreement. The patent provides coverage of biomarkers and the computation/statistical methods used to discriminate the disease vs. the normal controls.
“Power3 Medical is continuing the portfolio of it intellectual property in Neurodegenerative diagnosis”, We recently filed a patent on the ability of Power3;s Nuro-Pro-PD test, using a series of abnormal blood serum biomarkers, to distinguish the early onset of Parkinson’s disease ,” stated Dr. Ira L. Goldknopf, President and Chief Scientific Officer of Power3. “This patent is a break through declaration of new discoveries in this field”
“We are continually increasing our value with the exemplary patent filings for our biomarker discovery and validation. This is especially timely for the Nuro-Pro PD since we are striving to commercialize with our Collaborator, Transgenomic, Inc., via. CLIA testing in the late fall of 2009.” Commented Ms. Helen R. Park, CEO of Power3. “This adds value to Power3 and to our Licensee/Collaborator, Transgenomic, Inc.”
About Power3 Medical Products, Inc.
Power3 Medical Products, Inc. (OTCBB:PWRM) (www.Power3Medical.com), is a leading Bio Medical company engaged in the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets. Power3’s patent-pending technologies are being used to develop screening and diagnostic tests for the early detection and prognosis of disease, identify protein biomarkers, and drug targets. Power3 operates a state-of-the-art CLIA certified laboratory in The Woodlands (Houston), Texas. The Company continues to evolve and enhance its IP portfolio.
Forward Looking Statement
This press release contains forward-looking statements within the meaning of section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. With the exception of historical information contained herein, the matters discussed in this press release involve risk and uncertainties. Actual results could differ materially from those expressed in any forward-looking statement.
Contact:
Power3 Medical Products, Inc., The Woodlands, TX
CEO
Helen R. Park, M.S., 281-466-1600
Fax: 281-466-1481
hpark@power3medical.com
www.power3medical.com

Source: Power3 Medical Products, Inc.

Sign up to receive FREE stock-pr alerts from CRWENewswire.com http://www.crwenewswire.com/?tag=stock-pr

About CRWENewswire.com

CRWENewswire.com is an independent electronic informative online financial news publication company dedicated in providing company associates, business and financial professionals with economic and investment information, as well as stock highlights. CRWENewswire.com is a division of Crown Equity Holdings, Inc.
CRWENewswire.com is not a registered investment advisor or broker-dealer. CRWENewswire.com and Crown Equity Holdings, Inc., (CRWE) affiliates, officers, directors, contractors and employees, including may buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own Due Diligence before investing in any of the stocks mentioned above.

Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment (read more) Rule 17B requires disclosure of payment for investor relations.

Crown Equity Holdings, Inc. (CRWE.OB) anticipate being compensated five thousand dollars from a third party for 30 days of advertisement services for Power 3 Medical Products Inc. (PWRM.OB)

Stock-PR Reports U.S. Stocks

(LVS) Las Vegas Sands Corp.’s second-quarter loss widened amid charges and declining revenue as the casino giant also increased its cost savings target to about $500 million a year. LVS Shares dropped 5.8% to $10.50 in after-hours trading as net revenue fell short estimates.

(CEC) CEC Entertainment Inc.’s second-quarter profit fell 20% In after-hours trading, CEC shares slipped 2% to $33 as the results fell slightly short of analysts’ expectations. The stock has nearly tripled from its low last November.

(TOMO) Tomotherapy Inc. widened its second-quarter loss as revenue fell 21%, yet results came in ahead of analyts’ estimates. TOMO Shares of the company rose 14% to $3.25

Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment (read more) Rule 17B requires disclosure of payment for investor relations.

Genworth Financial Inc. (GNW) second-quarter loss narrowed as the company reported sharply smaller investment losses.
GNW shares fell 6.5% at $6.65 in after-hours trading as earnings excluding investment impacts were far below analysts’ expectations, giving back the stock’s regular session gains.

First Solar, Inc. (FSLR) second-quarter profit more than doubled on higher revenue and margins.
First Solar shares 4.8% to $181.95 in after-hours trading as results topped analysts’ estimates. Evergreen added 7.5% to $2.20.

(NVTL) Novatel Wireless shares rose 13% to $10.50 after the company reported second-quarter revenue above Wall Street expectations.

Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment (read more) Rule 17B requires disclosure of payment for investor relations.